Braveheart Bio, Inc. BRVE
CIK 0002131524
Form 4 transactions dated Nov 1, 2023 to Nov 15, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $159.03M
- Sold
- $0.00
Nov 1, 2023 – Aug 11, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| Aug 7, 2026 | Andreessen Marc L · HOROWITZ BENJAMIN A · AH Bio Fund IV, L.P. · AH Equity Partners Bio IV, L.L.C. 10% owner | Purchase | $19.80M 1,100,000 shares bought | Unavailable Indirect holding | ▾ |
| Aug 7, 2026 | Chimovits Erez Director · 10% owner | Purchase | $34.92M 1,940,000 shares bought | Unavailable Indirect holding | ▾ |
| Aug 7, 2026 | ORBIMED ADVISORS LLC · OrbiMed Genesis GP LLC · OrbiMed Capital GP IX LLC Director · 10% owner | Purchase | $34.92M 1,940,000 shares bought | Unavailable Indirect holding | ▾ |
| Aug 7, 2026 | Rickey James Paul Chief Financial Officer | Purchase | $499.99K 27,777 shares bought | 5.63% added Direct holding | ▾ |
| Aug 7, 2026 | Viehbacher Christopher Director | Purchase | $1.50M 83,333 shares bought | 15.84% added Direct holding | ▾ |
| Aug 7, 2026 | Malek David I Director | Purchase | $74.99K 4,166 shares bought | 0.79% added Direct holding | ▾ |
| Aug 7, 2026 | Anderson Michele A. Chief Development Officer | Purchase | $20.00K 1,111 shares bought | 0.34% added Direct holding | ▾ |
| Aug 7, 2026 | Murdoch Travis CEO and President · Director | Purchase | $1.50M 83,333 shares bought | 2.92% added Direct holding | ▾ |
| Aug 7, 2026 | Lubner David Charles Director | Purchase | $999.99K 55,555 shares bought | New holding Direct holding | ▾ |
| Aug 7, 2026 | Forbion Growth III Management B.V. · Forbion Growth Opportunities Fund III Cooperatief U.A. · Forbion Ventures Fund VII Cooperatief U.A. · Forbion Ventures VII Management B.V. 10% owner | Purchase | $34.56M 1,920,000 shares bought | Unavailable Direct holding | ▾ |
Showing 11 / 11 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 11 of 11 purchase / sale groups and 21 of 21 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_insider_transactions
{"action":"list","ticker":"BRVE","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.